Meilleure Health International Industry Group Limited

Equities

2327

BMG5975D1048

Construction Materials

Market Closed - Hong Kong S.E. 04:09:00 2024-05-03 am EDT 5-day change 1st Jan Change
0.155 HKD +1.97% Intraday chart for Meilleure Health International Industry Group Limited +6.16% -36.99%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Meilleure Health's 2023 Profit, Revenue Rise MT
Meilleure Health International Industry Group Limited Announces Board and Committees Changes CI
Meilleure Health International Industry Group Limited Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 20 August 2024 CI
Meilleure Health International Industry Group Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Meilleure Health International Industry Group Limited Provides Preliminary Consolidated Earnings Guidance for the Year Ended 31 December 2023 CI
Meilleure Health Sells 661,408 Shares of Hanshang Group MT
Meilleure Health to Extend 200 Million Yuan Revolving Loan Facility to Affiliate MT
Meilleure Health to Buy 3 Properties from Affiliate MT
Meilleure Health International Industry Group Limited Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Meilleure Health International Industry's Profit to Rise in H1 MT
Meilleure Health International Industry Group Limited Provides Consolidated Earnings Guidance for the Six Months Ended 30 June 2023 CI
Meilleure Health International Industry Group Limited commences an Equity Buyback Plan for 409,375,663 shares, representing 10% of its issued share capital, under the authorization approved on June 27, 2023. CI
Meilleure Health Further Disposes of Hanshang Shares for HK$7.1 Million MT
Meilleure Health Sells 1.4 Million Shares in Hanshang Group MT
Jiangsu Guangyu Zhaoneng New Energy Technology Co., Ltd. announced that it has received CNY 140 million in funding from a group of investors CI
Meilleure Health International Industry Group Limited Approves Final Dividend of the Financial Year Ended 31 December 2022 CI
Meilleure Health International Industry Group Limited's Equity Buyback announced on June 27, 2022, has expired. CI
Meilleure Health International Industry Group Limited Announces Board Changes CI
Meilleure Health's 2022 Attributable Profit Plunges; Shares Down 4% MT
Meilleure Health International Industry Group Limited Proposes Final Dividend for the Year Ended 31 December 2022, Payable on 22 August 2023 CI
Meilleure Health International Industry Group Limited Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Meilleure Health Forecasts Plunge in FY22 Profit MT
Meilleure Health Posts Profit Drop for First Half MT
Meilleure Health International Industry Group Limited(SEHK:2327) dropped from S&P Global BMI Index CI
Meilleure Health International Industry Group Limited Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Chart Meilleure Health International Industry Group Limited
More charts
Meilleure Health International Industry Group Limited is an investment holding company principally engaged in the trading of health care products, chemical materials and building materials. The Company operates its business through five segments. The Trading of Health Care Products, Chemical Materials and Building Materials segment is engaged in the trading of health care products, chemical materials and building materials. The Research and Development segment is engaged in the research and development of chemical and biological products. The Investment and Treasury Function segment is engaged in investment holding and treasury function. The Consultancy and Agency Business segment is engaged in the provision of property agency and consultancy service. The Property Development segment is engaged in the development of residential properties.
More about the company

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 2327 Stock
  4. News Meilleure Health International Industry Group Limited
  5. Meilleure Health International Industry's Profit to Rise in H1